Berridge, M. J. (2002). The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium, 32(5-6), 235–249. https://doi.org/10.1016/S0143416002001823.
Article CAS PubMed Google Scholar
Cybulsky, A. V. (2017). Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases. Nature Reviews Nephrology, 13(11), 681–696. https://doi.org/10.1038/nrneph.2017.129.
Article CAS PubMed Google Scholar
Hetz, C., Axten, J. M., & Patterson, J. B. (2019). Pharmacological targeting of the unfolded protein response for disease intervention. Nature Chemical Biology, 15(8), 764–775. https://doi.org/10.1038/s41589-019-0326-2.
Article CAS PubMed Google Scholar
Harada, M., Takahashi, N., Azhary, J. M., Kunitomi, C., Fujii, T., & Osuga, Y. (2021). Endoplasmic reticulum stress: a key regulator of the follicular microenvironment in the ovary. Molecular Human Reproduction, 27(1), gaaa088. https://doi.org/10.1093/molehr/gaaa088.
Article CAS PubMed Google Scholar
Ron, D., & Walter, P. (2007). Signal integration in the endoplasmic reticulum unfolded protein response. Nature Reviews Molecular Cell Biology, 8, 519–529. https://doi.org/10.1038/nrm2199.
Article CAS PubMed Google Scholar
Rutkowski, D. T., & Kaufman, R. J. (2007). That which does not kill me makes me stronger: adapting to chronic ER stress. Trends in Biochemical Sciences, 32(10), 469–476. https://doi.org/10.1016/j.tibs.2007.09.003.
Article CAS PubMed Google Scholar
Lievremont, J. P., Rizzuto, R., Hendershot, L., & Meldolesi, J. (1997). BiP, a major chaperone protein of the endoplasmic reticulum lumen, plays a direct and important role in the storage of the rapidly exchanging pool of Ca2+. Journal of Biological Chemistry, 272(49), 30873–30879. https://pubmed.ncbi.nlm.nih.gov/9388233/
Article CAS PubMed Google Scholar
Lee, A. S. (2005). The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods, 35(4), 373–381. https://pubmed.ncbi.nlm.nih.gov/15804610/
Article CAS PubMed Google Scholar
Oakes, S. A., & Papa, F. R. (2015). The role of endoplasmic reticulum stress in human pathology. Annual Review of Pathology: Mechanisms of Disease, 10, 173–194.
Jakubowicz, D. J., Seppala, M., Jakubowicz, S., Rodriguez-Armas, O., Rivas-Santiago, A., & Koistinen, H., et al. (2001). Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism, 86(3), 1126–1133. https://doi.org/10.1210/jcem.86.3.7295.
Article CAS PubMed Google Scholar
Berger, J. J., & Bates, G. W. (2014). Optimal management of subfertility in polycystic ovary syndrome. International Journal of Women's Health, 6, 613–621. https://doi.org/10.2147/IJWH.S48527.
Article PubMed PubMed Central Google Scholar
Rosas, C., Orostica, L., Poblete, C., Carvajal, R., Gabler, F., & Romero, C., et al. (2016). Hyperandrogenism decreases GRP78 protein level and glucose uptake in human endometrial stromal cells. Reproductive Sciences, 23(6), 761–770. https://doi.org/10.1177/1933719115618283.
Article CAS PubMed Google Scholar
Azhary, J. M. K., Harada, M., Kunitomi, C., Kusamoto, A., Takahashi, N., & Nose, E., et al. (2020). Androgens increase accumulation of advanced glycation end products in granulosa cells by activating ER stress in PCOS. Endocrinology, 161(2), bqaa015 https://pubmed.ncbi.nlm.nih.gov/32020188/
Brenjian, S., Moini, A., Yamini, N., Kashani, L., Faridmojtahedi, M., & Bahramrezaie, M., et al. (2020). Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers. American Journal of Reproductive Immunology, 83(1), e13186. https://doi.org/10.1111/aji.13186.
Emincik, A., Gungor, Z. B., & Guzel, E. (2020). Effects of salubrinal on ER stress in an experimental model of polycystic ovary syndrome. Ultrastructural Pathology, 44(4-6), 422–435. https://doi.org/10.1080/01913123.2020.1850963.
Article CAS PubMed Google Scholar
Jin, J., Ma, Y., Tong, X., Yang, W., Dai, Y., & Pan, Y., et al. (2020). Metformin inhibits testosterone-induced endoplasmic reticulum stress in ovarian granulosa cells via inactivation of p38 MAPK. Human Reproduction, 35(5), 1145–1158. https://doi.org/10.1093/humrep/deaa077.
Article CAS PubMed PubMed Central Google Scholar
Giudice, L. C. (2006). Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best Practice and Research Clinical Endocrinology and Metabolism, 20(2), 235–244.
Article CAS PubMed Google Scholar
Hector, N. A., & Mitchell, B. F. (2010). Physiological pathways and molecular mechanisms regulating uterine contractility. Human Reproduction Update, 16(6), 725–744. https://doi.org/10.1093/humupd/dmq016.
Hosseinzadeh, P., Barsky, M., Gibbons, W. E., & Blesson, C. S. (2021). Polycystic ovary syndrome and the forgotten uterus. F&S Reviews, 2(1), 11–20. https://doi.org/10.1016/j.xfnr.2020.12.001.
Wang, J. X., Davies, M. J., & Norman, R. J. (2001). Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Human Reproduction, 16(12), 2606–2609. https://doi.org/10.1093/humrep/16.12.2606.
Article CAS PubMed Google Scholar
Henmi, H., Endo, T., Nagasawa, K., Hayashi, T., Chida, M., & Akutagawa, N., et al. (2001). Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats. Biology of Reproduction, 64(1), 157–162. https://pubmed.ncbi.nlm.nih.gov/11133670/
Article CAS PubMed Google Scholar
Ben Mosbah, I., Alfany-Fernández, I., Martel, C., Zaouali, M. A., Bintanel-Morcillo, M., & Rimola, A., et al. (2010). Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death and Disease, 1(7), e52. https://doi.org/10.1038/cddis.2010.29.
Article CAS PubMed PubMed Central Google Scholar
Zhang, X., Zhang, C., Shen, S., Xia, Y. J., Yi, L., & Gao, Q., et al. (2013). Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats. Human Reproduction, 28(11), 3074–3085. https://doi.org/10.1093/humrep/det341.
Article CAS PubMed Google Scholar
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015). Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocrine Reviews, 36(5), 487–525. https://doi.org/10.1210/er.2015-1018.
Article CAS PubMed PubMed Central Google Scholar
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016). Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility, 106(1), 6–15. https://doi.org/10.1016/j.fertnstert.2016.05.003.
Zuo, T., Zhu, M., & Xu, W. (2016). Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxidative Medicine and Cellular Longevity, 2016, 8589318. https://doi.org/10.1155/2016/8589318.
Article CAS PubMed Google Scholar
Palomba, S., Daolio, J., & La Sala, G. B. (2017). Oocyte competence in women with polycystic ovary syndrome. Trends in Endocrinology and Metabolism, 28(3), 186–198. https://doi.org/10.1016/j.tem.2016.11.008.
Article CAS PubMed Google Scholar
Khashchenko, E., Vysokikh, M., Uvarova, E., Krechetova, L., Vtorushina, V., & Ivanets, T., et al. (2020). Activation of systemic inflammation and oxidative stress in adolescent girls with polycystic ovary syndrome in combination with metabolic disorders and excessive body weight. Journal of Clinical Medicine, 9(5), 1399.
留言 (0)